<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">297306</id>
  <title nil="true"/>
  <common-name>[(2r,3r,4s,5r)-3,4-diacetyloxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl acetate</common-name>
  <description>[(2r,3r,4s,5r)-3,4-diacetyloxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl acetate belongs to the pyrimidine nucleosides, a class of nucleosides, nucleotides, and analogues within the organic compounds. This compound has the formula C15H19N3O8 and an average molecular weight of 369.33 g/mol.</description>
  <cas>6742-07-0</cas>
  <pubchem-id>23192</pubchem-id>
  <chemical-formula>C15H19N3O8</chemical-formula>
  <weight>369.33</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-28T13:32:23Z</created-at>
  <updated-at type="dateTime">2026-08-28T13:32:23Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC(=O)OCC1C(C(C(O1)N2C=CC(=NC2=O)N)OC(=O)C)OC(=O)C</moldb-smiles>
  <moldb-formula>C15H19N3O8</moldb-formula>
  <moldb-inchi>InChI=1S/C15H19N3O8/c1-7(19)23-6-10-12(24-8(2)20)13(25-9(3)21)14(26-10)18-5-4-11(16)17-15(18)22/h4-5,10,12-14H,6H2,1-3H3,(H2,16,17,22)/t10-,12-,13+,14-/m1/s1</moldb-inchi>
  <moldb-inchikey>YTIZHZPRFYKRIG-RUZUBIRVSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">369.1172146</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>-0.8</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM293199</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>[(2r,3r,4s,5r)-3,4-diacetyloxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl acetate</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Nucleosides, nucleotides, and analogues</superklass>
  <klass>Pyrimidine nucleosides</klass>
  <subklass nil="true"/>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0248690</sync-id>
  <structure-inchikey>YTIZHZPRFYKRIG-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>2200108000000001000000100000000000000000000000000000000000000000200000000000000020000000000080000000000000040000000040000000000800400000022000000000208000000001000000000000000000000000000100000000020000000000000000000001000008000004000000005000100000400000000004000002008000000010c0100000000000000000000000000000000000000000000000080000000000000000004000000000000000200000000000000000000000000000000000000000000000000000000200000000000000000000000001400040010000000440000002000000000000000000000020</structure-fingerprint>
  <structure-pattern-fingerprint>5100020005128e0081000340016820000000140805152000003420c082300b4c44022013138000000100410800c80110056002a4108c32010004643100a04000c61104001290042000901060007203000804059051211b3240042462400089000c2805270048020064400200d5b40001208680700145e1041118082002910002d04e20884ef082080806024088ac0008191e0812446034020404082000c080a4005312000090c00002000960016d25100ac80001894108401800621008400212a10010a404d003b241800400151102800d010000020850200d0803040800130090104890088802200000001191122084001000308046800e000011007800040a</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAaAAAAGwAAAIABBgBgAAAAAQMGACgAAAAD
BAgAKAAAAAMCCAAoAAAAAwIGAGAAAAACAgYAYAAAAAMBBgBgAAAAAwEGAGAA
AAADAQYAYAAAAAMBCAAgAAAAAgdAKAAAAAMDBkBoAAAAAwMBBkBoAAAAAwMB
BkAoAAAAAwQHQCgAAAADAwZAKAAAAAMECAAoAAAAAwIHAGgAAAADAQIIACgA
AAADAgYAKAAAAAMECAAoAAAAAwIGAGAAAAABAwgAKAAAAAMCBgAoAAAAAwQI
ACgAAAADAgYAYAAAAAEDCwABAAECKAIBAyADBAAEBQAFBgAGBwAHCAAICQAI
CgAKC2gMCwxoDAwNaAwNDmgMDg9oDA8QKAINESAHEgASEyATFCgCExUABhYA
FhcgFxgoAhcZAAkFAA8KaAxCAgAAAAUFBgcICQYLDA0ODwoXBAAAAAAAAAAW
</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:08:15Z</structure-indexed-at>
</compound>
